Christina Lake Cannabis Stock Price

CNSX:CLCCA$11.2mPharmaceuticals & Biotech

CLC Share Price Performance

CLC Community Fair Values

RenovoRx
ST
Stock_Research_Today
Community Contributor
Revolutionizing Cancer Treatment
A Precision Approach to Hard-to-Treat Cancers RenovoRx, Inc. (Nasdaq: RNXT), based in Mountain View, California, is a clinical-stage biopharma company taking a new approach to cancer treatment.
View narrative
US$4.20
FV
66.9% undervalued intrinsic discount
371.30%
Revenue growth p.a.
11users have liked this narrative
3users have commented on this narrative
108users have followed this narrative
about 1 month ago author updated this narrative
Your Fair Value
CA$
Current Price
CA$0.04541.6% undervalued intrinsic discount
Growth estimate over
Annual revenue growth rate
%/yr
Decrease
Increase
Advanced

View all narratives

Recent CLC News & Updates

Christina Lake Cannabis Corp. Competitors

View more competitors

Christina Lake Cannabis Corp. Key Details

Last Reported Earnings

Nov 30, 2024

Yearly revenue growth

n/a

Earnings per share (EPS): 0.0035
Gross Margin: 66.88%
Net Profit Margin: 6.36%
Debt/Equity Ratio: 91.3%

View full report ›

Canadian Market Performance

7 Days: 0.4%
3 Months: 7.8%
1 Year: 15.7%
Year to Date: 6.1%

In the last week, the market has stayed flat, however the Materials sector stood out, gaining 4.1%. Meanwhile, the market is actually up 16% over the past year. Earnings are forecast to grow by 12% annually. Market details ›

🤖 A.I. Enters the “Show Me The Money” Phase

Richard Bowman

May 2025

The AI frenzy of 2023 and 2024 has cooled down and entered the "show me the money" phase. Earnings season has shed a lot of light on where we stand. So it’s time for an update on the industry and a look at the companies successfully deploying AI, monetizing it, and the potential opportunities for investors.

Last Week

Christina Lake Cannabis Stock Price

CLC Share Price Performance

CLC Community Fair Values

Revolutionizing Cancer Treatment

Recent CLC News & Updates

Christina Lake Cannabis Corp., Annual General Meeting, Jul 31, 2025

Christina Lake Cannabis Corp. announced that it expects to receive CAD 2.5 million in funding

Insufficient new directors

New major risk - Shareholder dilution

Full year 2024 earnings released: EPS: CA$0.007 (vs CA$0.032 loss in FY 2023)

Christina Lake Cannabis Corp. announced that it has received CAD 3.108375 million in funding from The Playford Family Limited Partnership

Third quarter 2024 earnings released: EPS: CA$0.032 (vs CA$0.019 in 3Q 2023)

Second quarter 2024 earnings released: CA$0.012 loss per share (vs CA$0.006 loss in 2Q 2023)

Christina Lake Cannabis Corp. Competitors

🤖 A.I. Enters the “Show Me The Money” Phase

🧬 The Convergence of Genomic Medicine and AI Drug Discovery